Stem Cell Research (Apr 2017)
Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience
- Paul A. De Sousa,
- Rachel Steeg,
- Elisabeth Wachter,
- Kevin Bruce,
- Jason King,
- Marieke Hoeve,
- Shalinee Khadun,
- George McConnachie,
- Julie Holder,
- Andreas Kurtz,
- Stefanie Seltmann,
- Johannes Dewender,
- Sascha Reimann,
- Glyn Stacey,
- Orla O'Shea,
- Charlotte Chapman,
- Lyn Healy,
- Heiko Zimmermann,
- Bryan Bolton,
- Trisha Rawat,
- Isobel Atkin,
- Anna Veiga,
- Bernd Kuebler,
- Blanca Miranda Serano,
- Tomo Saric,
- Jürgen Hescheler,
- Oliver Brüstle,
- Michael Peitz,
- Cornelia Thiele,
- Niels Geijsen,
- Bjørn Holst,
- Christian Clausen,
- Majlinda Lako,
- Lyle Armstrong,
- Shailesh K. Gupta,
- Alexander J. Kvist,
- Ryan Hicks,
- Anna Jonebring,
- Gabriella Brolén,
- Andreas Ebneth,
- Alfredo Cabrera-Socorro,
- Patrik Foerch,
- Martine Geraerts,
- Tina C. Stummann,
- Shawn Harmon,
- Carol George,
- Ian Streeter,
- Laura Clarke,
- Helen Parkinson,
- Peter W. Harrison,
- Adam Faulconbridge,
- Luca Cherubin,
- Tony Burdett,
- Cesar Trigueros,
- Minal J Patel,
- Christa Lucas,
- Barry Hardy,
- Rok Predan,
- Joh Dokler,
- Maja Brajnik,
- Oliver Keminer,
- Ole Pless,
- Philip Gribbon,
- Carsten Claussen,
- Annette Ringwald,
- Beate Kreisel,
- Aidan Courtney,
- Timothy E. Allsopp
Affiliations
- Paul A. De Sousa
- Centre for Clinical Brain Sciences, Chancellors Building, 49 Little France Crescent, University of Edinburgh, Edinburgh EH16 4SB, UK
- Rachel Steeg
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Elisabeth Wachter
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Kevin Bruce
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Jason King
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Marieke Hoeve
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Shalinee Khadun
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- George McConnachie
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Julie Holder
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Andreas Kurtz
- Charité - Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Augustenburger Platz, Berlin 13353, Germany
- Stefanie Seltmann
- Charité - Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Augustenburger Platz, Berlin 13353, Germany
- Johannes Dewender
- Charité - Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Augustenburger Platz, Berlin 13353, Germany
- Sascha Reimann
- Charité - Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Augustenburger Platz, Berlin 13353, Germany
- Glyn Stacey
- UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Authority, Blanche Lane, South Mimms, Hertfordshire, ENG 3GQ, UK
- Orla O'Shea
- UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Authority, Blanche Lane, South Mimms, Hertfordshire, ENG 3GQ, UK
- Charlotte Chapman
- UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Authority, Blanche Lane, South Mimms, Hertfordshire, ENG 3GQ, UK
- Lyn Healy
- UK Stem Cell Bank, Division of Advanced Therapies, National Institute for Biological Standards and Control, Medicines and Healthcare Products Regulatory Authority, Blanche Lane, South Mimms, Hertfordshire, ENG 3GQ, UK
- Heiko Zimmermann
- Fraunhofer Institute for Biomedical Engineering (IBMT), Josef-von-Fraunhofer-Weg 1, 66280 Sulzbach, Germany
- Bryan Bolton
- European Collection of Authenticated Cell Cultures, Public Health England, Porton Down, Salisbury SP4 0JG, UK
- Trisha Rawat
- European Collection of Authenticated Cell Cultures, Public Health England, Porton Down, Salisbury SP4 0JG, UK
- Isobel Atkin
- European Collection of Authenticated Cell Cultures, Public Health England, Porton Down, Salisbury SP4 0JG, UK
- Anna Veiga
- Barcelona Stem Cell Bank, Centre for Regenerative Medicine in Barcelona, C/Dr. Aiguader 88, 08003 Barcelona, Spain
- Bernd Kuebler
- Barcelona Stem Cell Bank, Centre for Regenerative Medicine in Barcelona, C/Dr. Aiguader 88, 08003 Barcelona, Spain
- Blanca Miranda Serano
- Andalusian Public Health Care System, Avda Conocimiento sn, 18100 Armilla, Granada, Spain
- Tomo Saric
- Centre for Physiology and Pathophysiology, Institute for Neurophysiology, Medical Faculty, University of Cologne, 50931 Cologne, Germany
- Jürgen Hescheler
- Centre for Physiology and Pathophysiology, Institute for Neurophysiology, Medical Faculty, University of Cologne, 50931 Cologne, Germany
- Oliver Brüstle
- Institute of Reconstructive Neurobiology, LIFE & BRAIN Centre, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany
- Michael Peitz
- Institute of Reconstructive Neurobiology, LIFE & BRAIN Centre, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany
- Cornelia Thiele
- Institute of Reconstructive Neurobiology, LIFE & BRAIN Centre, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany
- Niels Geijsen
- Hubrecht Institute for developmental biology and stem cell research, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht University, Department of Clinical Sciences of Companion Animals and UMC Utrecht, 3584CT Utrecht, The Netherlands
- Bjørn Holst
- Bioneer A/S, Kogle Alle 2, DK-2970 Hørsholm, Denmark
- Christian Clausen
- Bioneer A/S, Kogle Alle 2, DK-2970 Hørsholm, Denmark
- Majlinda Lako
- Institute for Genetic Medicine, University of Newcastle, Newcastle NE1 3BZ, United Kingdom
- Lyle Armstrong
- Institute for Genetic Medicine, University of Newcastle, Newcastle NE1 3BZ, United Kingdom
- Shailesh K. Gupta
- AstraZeneca, R&D, Innovative Medicines, Discovery Sciences, Reagents and Assay Development, HC3006, Pepparedsleden 1, SE-431 83 Mölndal, Sweden
- Alexander J. Kvist
- AstraZeneca, R&D, Innovative Medicines, Discovery Sciences, Reagents and Assay Development, HC3006, Pepparedsleden 1, SE-431 83 Mölndal, Sweden
- Ryan Hicks
- AstraZeneca, R&D, Innovative Medicines, Discovery Sciences, Reagents and Assay Development, HC3006, Pepparedsleden 1, SE-431 83 Mölndal, Sweden
- Anna Jonebring
- AstraZeneca, R&D, Innovative Medicines, Discovery Sciences, Reagents and Assay Development, HC3006, Pepparedsleden 1, SE-431 83 Mölndal, Sweden
- Gabriella Brolén
- AstraZeneca, R&D, Innovative Medicines, Discovery Sciences, Reagents and Assay Development, HC3006, Pepparedsleden 1, SE-431 83 Mölndal, Sweden
- Andreas Ebneth
- Janssen Research & Development (A Division of Janssen Pharmaceutica N.V), Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium
- Alfredo Cabrera-Socorro
- Janssen Research & Development (A Division of Janssen Pharmaceutica N.V), Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium
- Patrik Foerch
- UCB Biopharma (since May 2014), Discovery Research, Chemin du Foriest, Braine l'Alleud B-1420, Belgium
- Martine Geraerts
- UCB Biopharma (since May 2014), Discovery Research, Chemin du Foriest, Braine l'Alleud B-1420, Belgium
- Tina C. Stummann
- H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark
- Shawn Harmon
- University of Edinburgh School of Law, Old College, South Bridge, Edinburgh EH8 9YL, UK
- Carol George
- University of Edinburgh School of Law, Old College, South Bridge, Edinburgh EH8 9YL, UK
- Ian Streeter
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
- Laura Clarke
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
- Helen Parkinson
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
- Peter W. Harrison
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
- Adam Faulconbridge
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
- Luca Cherubin
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
- Tony Burdett
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
- Cesar Trigueros
- Inbiomed, P° Mikeletegi, 81, 20009 San Sebastián, Gipuzkoa, Spain
- Minal J Patel
- Cellular Generation and Phenotyping (CGaP) facility, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinston CB10 1SA, UK
- Christa Lucas
- Cellular Generation and Phenotyping (CGaP) facility, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinston CB10 1SA, UK
- Barry Hardy
- Douglas Connect, Technology Park Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland
- Rok Predan
- Douglas Connect, Technology Park Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland
- Joh Dokler
- Douglas Connect, Technology Park Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland
- Maja Brajnik
- Douglas Connect, Technology Park Basel, Hochbergerstrasse 60C, 4057 Basel, Switzerland
- Oliver Keminer
- Fraunhofer IME ScreeningPort, Schnackenburgallee 114, D-22525 Hamburg, Germany
- Ole Pless
- Fraunhofer IME ScreeningPort, Schnackenburgallee 114, D-22525 Hamburg, Germany
- Philip Gribbon
- Fraunhofer IME ScreeningPort, Schnackenburgallee 114, D-22525 Hamburg, Germany
- Carsten Claussen
- Fraunhofer IME ScreeningPort, Schnackenburgallee 114, D-22525 Hamburg, Germany
- Annette Ringwald
- ARTTIC, 58A rue du Dessous des Berges, F-75013 Paris, France
- Beate Kreisel
- ARTTIC, 58A rue du Dessous des Berges, F-75013 Paris, France
- Aidan Courtney
- Roslin Cells Ltd, Head office, Nine Edinburgh Bioquarter, 9 Little France Rd, Edinburgh EH16 4UX, UK
- Timothy E. Allsopp
- Pfizer Ltd (Neusentis), The Portway Building, Granta Park, Great Abington, Cambridge, CB21 6GS, UK
- DOI
- https://doi.org/10.1016/j.scr.2017.03.002
- Journal volume & issue
-
Vol. 20,
no. C
pp. 105 – 114
Abstract
A fast track “Hot Start” process was implemented to launch the European Bank for Induced Pluripotent Stem Cells (EBiSC) to provide early release of a range of established control and disease linked human induced pluripotent stem cell (hiPSC) lines. Established practice amongst consortium members was surveyed to arrive at harmonised and publically accessible Standard Operations Procedures (SOPs) for tissue procurement, bio-sample tracking, iPSC expansion, cryopreservation, qualification and distribution to the research community. These were implemented to create a quality managed foundational collection of lines and associated data made available for distribution. Here we report on the successful outcome of this experience and work flow for banking and facilitating access to an otherwise disparate European resource, with lessons to benefit the international research community. eTOC: The report focuses on the EBiSC experience of rapidly establishing an operational capacity to procure, bank and distribute a foundational collection of established hiPSC lines. It validates the feasibility and defines the challenges of harnessing and integrating the capability and productivity of centres across Europe using commonly available resources currently in the field.